U.s. Army Medical Research And Development Command

This early-stage study tested the safety of different amounts of a vaccine booster (called ALFQ) when combined with an experimental HIV vaccine. Sixty-five healthy adults who don't have HIV received three shots over two months. Researchers compared three groups getting different …

This study tested a new rapid diagnostic device called CL Detect™ to see how well it identifies cutaneous leishmaniasis, a parasitic skin disease. Researchers enrolled 150 adults with skin ulcers and compared results from the new quick test to the standard, slower lab method. The…

This study tested an experimental antibody injection, called G03-52-01, to see if it could safely protect healthy adults from illness caused by botulinum toxin. About 622 participants received either the antibody or a placebo shot to compare safety and measure the body's protecti…